References
R.V. Lloyd, R.Y. Osamura, G. Kloppel, J. Rosai, WHO Classification of Tumors of Endocrine Organs (WHO International Agency, Lion France, 2017)
A. Fusco, F. Lugli, E. Sacco, L. Tilaro, A. Bianchi, F. Angelini, A. Tofani, A. Barini, L. Lauriola, G. Maira, A. Pontecorvi, L. De Marinis, Efficacy of the combined cabergoline and octreotide treatment in a case of a dopamine-agonist resistant macroprolactinoma. Pituitary 14, 351–357 (2011). https://doi.org/10.1007/s11102-008-0162-y
S.W.J. Lamberts, L.J. Hofland, Future treatment strategies of aggressive pituitary tumors. Pituitary 12, 261–264 (2009). https://doi.org/10.1007/s11102-008-0154-y
Acknowledgements
This case is a courtesy of Prof. Laura De Marinis, Chair of Pituitary Unit of the Department of Endocrinology. All the authors wish to thank Prof. Laura De Marinis, who manages and follows-up the patient and offers clinical data for the paper. Moreover the authors wish to thank Dr. Tommaso Tartaglione and Prof. Cesare Colosimo (Institute of Radiology), Dr. Germano Perotti and Prof. Alessandro Giordano (Department of Nuclear Medicine) for the diagnostic and images support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Del Gatto, V., Bima, C., Chiloiro, S. et al. Use of 111In-pentetreotide scintigraphy for diagnosis and management of resistant macroprolactinoma. Endocrine 60, 532–534 (2018). https://doi.org/10.1007/s12020-017-1486-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-017-1486-z